Le fait de fermer ne sauvegardera pas votre configuration à moins que vous n'ajoutiez l'article à votre Panier d'achat ou à vos Favoris.
Cliquer sur OK pour fermer l'outil MILLIPLEX® MAP ou sur Annuler pour retourner à votre sélection.
Choisissez des Panels configurables & des Kits préconfigurés - OU - des MAPmate™ de signalisation cellulaire
Concevez vos kits MILLIPLEX® MAP et obtenez leur prix.
Panels configurables & Kits préconfigurés
Notre large gamme est constituée de panels multiplex qui vous permettent de choisir, au sein d'un panel, les analytes qui répondent le mieux à vos besoins. Sur un autre onglet, vous pouvez choisir un format cytokine préconfiguré ou un kit Simplex.
Kits de signalisation cellulaire & MAPmate™
Choisissez des kits préconfigurés qui permettent d'explorer l'ensemble des voies ou des processus. Ou concevez vos propres kits en choisissant des Simplex MAPmate™ et en suivant les instructions fournies.
Les MAPmate™ suivants ne peuvent pas être utilisés ensemble : -des MAPmate™ qui nécessitent des tampons différents -des paires de MAPmate™ totaux et phospho-spécifiques, par ex. GSK3β total et GSK3β (Ser 9) -des MAPmate™ PanTyr et spécifiques d'un site, par ex. Récepteur Phospho-EGF et phospho-STAT1 (Tyr701) -Plus d'un phospho-MAPmate™ pour une seule cible (Akt, STAT3). -GAPDH et β-Tubuline ne peuvent pas être utilisés avec les kits ou les MAPmate™ contenant panTyr.
.
Référence
Guide d'achat
Qté
Liste
Cet article a été ajouté à vos favoris.
Sélectionner une espèce, un type de panel, un kit ou un type d'échantillon
Pour commencer à concevoir votre kit MILLIPLEX® MAP, sélectionnez une espèce, un type de panel ou un kit d'intérêt.
Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
Cet article a été ajouté à vos favoris.
Espèce
Type de panel
Kit sélectionné
Qté
Référence
Guide d'achat
Qté
Prix tarif
96-Well Plate
Qté
Référence
Guide d'achat
Qté
Prix tarif
Ajouter des réactifs supplémentaires (Un kit "Buffer and Detection Kit" est nécessaire pour une utilisation avec les MAPmate™)
Qté
Référence
Guide d'achat
Qté
Prix tarif
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Option de gain de place Nos clients qui commandent plusieurs kits peuvent choisir d'économiser de l'espace de stockage en éliminant l'emballage de chaque kit et de recevoir les composants de leur essai multiplex conditionnés sous poches en plastique pour un stockage plus compact.
Cet article a été ajouté à vos favoris.
Ce produit a été ajouté à votre panier.
Vous pouvez maintenant concevoir un autre kit personnalisé, choisir un kit pré-configuré, régler vos achats ou fermer l'outil de commande.
IM09L
Sigma-AldrichAnti-MMP-9 (Ab-1) Mouse mAb (6-6B)
This Anti-MMP-9 (Ab-1) Mouse mAb (6-6B) is validated for use in Immunoblotting, Immunoprecipitation, Neutralization Studies, Paraffin Sections for the detection of MMP-9 (Ab-1).
More>>This Anti-MMP-9 (Ab-1) Mouse mAb (6-6B) is validated for use in Immunoblotting, Immunoprecipitation, Neutralization Studies, Paraffin Sections for the detection of MMP-9 (Ab-1). Less<<
Anti-MMP-9 (Ab-1) Mouse mAb (6-6B) : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
Le champ quantité est vide. Veuillez saisir une quantité supérieure ou égale à 1 au minimum pour ajouter des articles à votre panier.
Description
Overview
Recognizes the ~92 kDa latent and the ~83 kDa active forms of MMP-9 under non-reducing conditions, but only the latent form under reducing conditions. Inhibits the enzymatic activity of MMP-9. For paraffin sections, use Cat. No. IM37L.
Catalogue Number
IM09L
Brand Family
Calbiochem®
Synonyms
Anti-92 kDa Gelatinase, Anti-Matrix Metalloproteinase 9, Anti-Type IV Collagenase, Anti-Gelatinase B
References
References
Cottam, D.W. and Rees, R.C. 1993. Intl. J. of Oncol.2, 861. Nakajima, M., et al. 1993. Cancer Res.53, 5802. Ramos-DeSimone, et al. 1993. Hybridoma. 12, 349. Stetler-Stevenson, W.G., et al. 1993. FASEB.7, 1434. Zucker, S., et al. 1993. Cancer Res.53, 140. Woessner, J.F. 1991. FASEB. 5, 2145. Liotta, L.A. and Stetler-Stevenson, W.G. 1990. in Seminars in Cancer Biology, ed. M.M. Gottesman. Vol. 1; 99-106.
Immunoprecipitation
Ramos-DeSimone, N. and French, D. L. 1994. Ann. NY Acad. Sci.732, 469.
Immunoblotting, Neutralization Studies
Ramos-DeSimone, N., et al. 1993. Hybridoma.12, 349.
Key Applications
Immunoblotting (Western Blotting)
Immunoprecipitation
Not Paraffin Sections
Neutralization Studies
Application Notes
Immunoblotting (2 µg/ml) Immunoprecipitation (see appplication references) Neutralization Studies (see comments and application references) Paraffin Sections (not recommended)
Application Comments
Inhibits MMP-9 enzymatic activity. For staining paraffin sections, use Anti-MMP-9 (626-644) (Ab-3) Mouse mAb (56-2A4) (Cat. No. IM37L). Antibody should be titrated for optimal results in individual systems.
Biological Information
Immunogen
MMP-9 from conditioned medium of PMA-stimulated HT-1080 human fibrosarcoma cells
Immunogen
Human
Clone
6-6B
Host
Mouse
Isotype
IgG₁
Species Reactivity
Human
Antibody Type
Monoclonal Antibody
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code
Ambient Temperature Only
Toxicity
Standard Handling
Storage
+2°C to +8°C
Do not freeze
Ok to freeze
Special Instructions
Store at 4°C until reconstituted, then store in aliquots at -20°C or at 4°C with 0.1% azide. Resuspend the antibody with sterile PBS, pH 7.4, or sterile 20 mM Tris-saline, pH 7.4, to yield a final concentration of 100 µg/ml; product will be more stable if 0.1% sodium azide is included (do not add azide if antibody is to be used with viable cells). Lyophilized antibodies should be resuspended at 4°C with occasional gentle mixing for at least 2 h. Freezing of aliquots is best for long-term storage of reconstituted product; repetitive freezing and thawing should be avoided.
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Référence
GTIN
IM09L-100UG
04055977228151
Documentation
Anti-MMP-9 (Ab-1) Mouse mAb (6-6B) Certificats d'analyse
Titre
Numéro de lot
IM09L
Références bibliographiques
Aperçu de la référence bibliographique
Cottam, D.W. and Rees, R.C. 1993. Intl. J. of Oncol.2, 861. Nakajima, M., et al. 1993. Cancer Res.53, 5802. Ramos-DeSimone, et al. 1993. Hybridoma. 12, 349. Stetler-Stevenson, W.G., et al. 1993. FASEB.7, 1434. Zucker, S., et al. 1993. Cancer Res.53, 140. Woessner, J.F. 1991. FASEB. 5, 2145. Liotta, L.A. and Stetler-Stevenson, W.G. 1990. in Seminars in Cancer Biology, ed. M.M. Gottesman. Vol. 1; 99-106.
Fiche technique
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
Revision
27-August-2007 RFH
Synonyms
Anti-92 kDa Gelatinase, Anti-Matrix Metalloproteinase 9, Anti-Type IV Collagenase, Anti-Gelatinase B
Application
Immunoblotting (2 µg/ml) Immunoprecipitation (see appplication references) Neutralization Studies (see comments and application references) Paraffin Sections (not recommended)
Description
Purified mouse monoclonal antibody. Recognizes the ~92 kDa latent and the ~83 kDa active forms of human MMP-9 under non-reducing conditions, but only the latent form under reducing conditions.
Background
Matrix metalloproteinases (MMP's) are a family of enzymes that are responsible for the degradation of extracellular matrix components such as collagen, laminin and proteoglycans. In addition to sequence homology, all MMP's share the following characteristics: the catalytic mechanism is dependent upon a zinc ion at the active center, they cleave one or more extracellular matrix components, they are secreted as zymogens which are activated by removal of an ~10 kDa segment from the N terminus and they are inhibited by tissue inhibitor of metalloproteinases (TIMP). These enzymes are involved in normal physiological processes such as embryogenesis and tissue remodeling and may play an important role in arthritis, periodontitis, and metastasis.
MMP-9 (Gelatinase B, 92 kDa gelatinase/type IV collagenase) is secreted as a 92 kDa zymogen which is proteolytically processed to the 83 kDa active form; a 68 kDa has also been detected. MMP-9, along with its most closely related member of the MMP family, MMP-2, show substrate specificity toward type IV and V collagens, gelatin and elastin. Numerous studies have shown a correlation between collagenase expression and metastatic potential. Elevated levels of MMP-9 in plasma suggest that it may be a useful marker for the diagnosis or prognosis of cancer in general.
Host
Mouse
Immunogen species
Human
Immunogen
MMP-9 from conditioned medium of PMA-stimulated HT-1080 human fibrosarcoma cells
Clone
6-6B
Isotype
IgG₁
Species
human
Positive control
MMP-9 protein (Cat. Nos. PF024 or PF038)
Form
Lyophilized
Formulation
Lyophilized from a volatile buffer, 100 µg BSA.
Preservative
None
Comments
Inhibits MMP-9 enzymatic activity. For staining paraffin sections, use Anti-MMP-9 (626-644) (Ab-3) Mouse mAb (56-2A4) (Cat. No. IM37L). Antibody should be titrated for optimal results in individual systems.
Storage
+2°C to +8°C
Do Not Freeze
Ok to freeze
Special Instructions
Store at 4°C until reconstituted, then store in aliquots at -20°C or at 4°C with 0.1% azide. Resuspend the antibody with sterile PBS, pH 7.4, or sterile 20 mM Tris-saline, pH 7.4, to yield a final concentration of 100 µg/ml; product will be more stable if 0.1% sodium azide is included (do not add azide if antibody is to be used with viable cells). Lyophilized antibodies should be resuspended at 4°C with occasional gentle mixing for at least 2 h. Freezing of aliquots is best for long-term storage of reconstituted product; repetitive freezing and thawing should be avoided.
Toxicity
Standard Handling
References
Cottam, D.W. and Rees, R.C. 1993. Intl. J. of Oncol.2, 861. Nakajima, M., et al. 1993. Cancer Res.53, 5802. Ramos-DeSimone, et al. 1993. Hybridoma. 12, 349. Stetler-Stevenson, W.G., et al. 1993. FASEB.7, 1434. Zucker, S., et al. 1993. Cancer Res.53, 140. Woessner, J.F. 1991. FASEB. 5, 2145. Liotta, L.A. and Stetler-Stevenson, W.G. 1990. in Seminars in Cancer Biology, ed. M.M. Gottesman. Vol. 1; 99-106.
Application references
Immunoprecipitation
Ramos-DeSimone, N. and French, D. L. 1994. Ann. NY Acad. Sci.732, 469.
Immunoblotting, Neutralization Studies
Ramos-DeSimone, N., et al. 1993. Hybridoma.12, 349.